IMPORTANCE Although a variety of well-characterized diseases, such as sarcoidosis and granulomatosis with polyangiitis, affect the lacrimal gland, many patients with dacryoadenitis are diagnosed as having nonspecific orbital inflammation (NSOI) on the basis of histology and systemic disease evaluation. The ability to further classify the disease in these patients should facilitate selection of effective therapies.
D acryoadenitis has a broad differential diagnosis that includes sarcoidosis, nonspecific orbital inflammation (NSOI), Sjögren syndrome, and, less commonly, entities like granulomatosis with polyangiitis (GPA), thyroid eye disease (TED), or IgG4-related disease. [1] [2] [3] [4] [5] Other considerations in the differential diagnosis are infections, tumors (including lymphoma), and lymphoid hyperplasia. Among these diagnoses, nonspecific inflammation is the most common biopsy diagnosis. 2 Although histopathology is certainly a component of the criterion standard for diagnosing diseases of the lacrimal gland, the approach has limitations. For example, GPA is a mediumsized vessel vasculitis, but vessels of that size are rarely present within a lacrimal specimen. Although the pathology of sarcoidosis includes granulomas, which are readily appreciated by histology, a sampling error might exclude granulomas from the tissue that is microscopically examined. The presence of IgG4-positive plasma cells is emerging as an important factor in lacrimal inflammation, 4 but the specificity of these cells has been questioned. 6 Clearly, there is opportunity to improve the diagnostic yield from lacrimal gland biopsy. Furthermore, an unresolved issue is whether nonspecific inflammation represents a single diagnostic entity or a variety of different inflammations. Implementation of molecular techniques has the potential to increase the accuracy and specificity of diagnosing the different forms of dacryoadenitis. For example, gene expression profiling can distinguish different causes of synovitis, 7 esophagitis, 8 or myocarditis. 9 Our group previously used gene expression profiling to characterize different causes of uveitis 10, 11 and orbital adipose tissue inflammation. [12] [13] [14] [15] In another study, 16 our group analyzed gene expression in blood, lacrimal gland, and orbital adipose tissue from individuals affected by sarcoidosis. In that study, a set of 40 messenger RNA transcripts was selected that were differentially expressed in all 3 diseased tissue samples of patients compared with the same tissue samples from healthy controls. We now have compared gene expression profiles of lacrimal gland from individuals having GPA, NSOI, sarcoidosis, or TED with profiles from healthy controls. Based on the 40 transcripts identified from our group's prior sarcoidosis study, 16 we used the mclust algorithm 17 to test the hypothesis that nonspecific lacrimal gland inflammation is a heterogeneous collection of diseases that sometimes resembles sarcoidosis. The study dates were March 2012 to April 2017.
Methods

Tissue Samples
We obtained 49 lacrimal gland biopsy specimens from 48 individuals (1 lacrimal gland from a patient with sarcoidosis was sampled from 2 separate locations) at the following 7 interna- 
Pathology Review
Two of us (D.J.W. and H.E.G.) were tasked with confirming the diagnosis from the institution where the biopsy was obtained and also independently scored each tissue on the basis of fibrosis, granulomas, lymphoid nodules, and inflammation. In each case, an ordinal scale from 0 to 3 was used, with the pathology scores reflecting none, mild, moderate, or marked change for each given descriptor. The scores of 2 of us (D.J.W. and H.E.G.) were in agreement two-thirds of the time. The scores were averaged for analyses.
RNA Extraction and Microarray
All tissue samples were sent to Oregon Health & Science University for RNA extraction and microarray as previously described. 12, 13, 16 In brief, complementary DNA was synthesized from purified RNA, amplified, labeled, and hybridized to arrays (U133 Plus 2.0; Affymetrix), which include probe sets for approximately 45 000 transcripts. Furthermore, our group has reported on the RNA quality and the correlation between our array data and quantitative polymerase chain reaction. 18 
Statistical Analysis
Files (CEL; Affymetrix) were imported into R statistical language, 19 and expression levels were calculated by the robust multiarray analysis. 20 The mclust algorithm 17 was used
Key Points
Question Is nonspecific orbital inflammation affecting the lacrimal gland a single disease or multiple different diseases, and is it a limited form of other diseases, such as sarcoidosis or granulomatosis with polyangiitis?
Findings This cohort study comparing the expression of 40 genes from biopsy specimens of 48 patients having lacrimal nonspecific orbital inflammation with healthy controls indicates that such inflammation is a heterogeneous collection of diseases and suggests that it is often a limited form of known lacrimal inflammation.
Meaning Gene expression patterns can subdivide lacrimal gland nonspecific orbital inflammation, having the potential to lead to more precise therapy and new insights into pathogenesis.
to cluster the normalized gene expression values of selected probe sets. A clustering analysis is a type of unsupervised machine learning that groups samples into clusters such that those within a cluster are more closely related to one another than those assigned to different clusters based on some dissimilarity measure. 21 Most of the conventional clustering algorithms, such as hierarchical clustering or K-means clustering, 22 require that the number of clusters be prespecified, which can be a subjective decision and disadvantage in applications. In contrast, the mclust algorithm assumes that samples are collected from a number of gaussian distributions (or normal distributions). First, the algorithm fits a range of different gaussian mixture models, and then it chooses an optimal number of gaussian distributions or clusters based on the Bayesian information criterion. 23 Therefore, the mclust algorithm can provide a more objective number of clusters than the conventional clustering algorithms. Heat maps and multidimensional scaling (MDS) plots were used to visualize the cluster analysis results. All computations were done using affy, limma, and mclust packages of R statistical language.
Selection of Discriminating Probe Sets
In our group's previous study 16 investigating gene expression differences due to sarcoidosis in blood, lacrimal gland, or orbital adipose tissue, we used linear models and empirical Bayes methods 24 while adjusting for potential confounding effects of age and sex. The linear models were fitted to each tissue type separately, and race was not included in the models due to too many missing values. Our group reported 159 Affymetrix probe sets indicating differential expression common to all 3 of these tissue samples (at least 1.5-fold change compared with healthy controls, with an adjusted false discovery rate of P < .05). 16 Among them, 45 probe sets had a false discovery rate of P < .005 and were used for the analyses shown in Figure 1 and Figure 2 . Because of redundancy in the probe sets, the 45 probe sets represent 40 different genes.
Results
Among 48 patients, the mean (SD) age was 41.6 (19.0) years, and 32 (67%) were female. We analyzed 49 lacrimal biopsy specimens from 48 patients, including 3 with GPA, 28 with NSOI, 7 with sarcoidosis, 4 with TED, and 6 healthy controls. The mean age and sex for each of these 5 groups are listed in the Table. Information on race is also provided. Although the groups differ in some comparisons on the basis of age, sex, or race, the differences are not statistically significant. Because of the numbers of specimens in each of our disease groups, we focused our initial analysis on 45 core probe sets that our group previously reported as discriminating between gene expression profiles of blood, lacrimal gland, and orbital adipose tissue from individuals having sarcoidosis compared with profiles from healthy controls. 16 Application of the mclust algorithm with the selected probe sets used unsupervised machine learning to separate the individuals into an optimal number of clusters or subsets with 5 different gene expression patterns based on the Bayesian information criterion. 23 Inclusion of additional probe sets that our group previously found to be differentially expressed in orbital adipose tissue samples from individuals with these diseases 12, 13, 15, 16 decreased the consistency of clustering as indicated by the mclust algorithm with the disease diagnosis. The mclust algorithm results based on the core probe sets are shown in the heat map (Figure 1 ) and the MDS plot (Figure 2 and Video). These probe sets discriminate among the healthy controls and the 3 known diseases (GPA, sarcoidosis, and TED). As seen in both the heat map and the MDS plot, 5 of the 6 healthy control biopsy specimens, 2 of the 3 GPA specimens, 6 of the 8 sarcoidosis specimens, and 3 of the 4 TED specimens cluster together. These same genes subdivide the NSOI biopsy specimens into the 4 clusters. Three of the 28 NSOI biopsy specimens have a gene expression pattern resembling sarcoidosis even though granulomas were not detected in the biopsy specimens by either pathologist. Clinical information was available on 2 of the 3 individuals with NSOI whose gene expression profile resembled sarcoidosis. Both individuals had received observation only without therapy, and neither had chest computed tomography imaging. Other NSOI biopsy specimens group with other diagnoses, including GPA or TED, and with healthy controls. In both Figures 1 and 2 , underlining is used to identify the 2 biopsy specimens from different portions of the lacrimal gland from the same individual. The pattern seen in the heat map and the proximity of the 2 data points shown in the MDS plot indicate that the reproducibility of the method is good.
We next analyzed the lacrimal biopsy specimens based on the pathologists' scoring for fibrosis, granulomas, lymphoid nodules, or inflammation. In Figure 3A , the biopsy specimens have been grouped based on the gene expression cluster. Using χ 2 analysis, the clusters differ for each of these 4 pathology scores, with χ 2 = 32.2, P = .01 for fibrosis, χ 2 = 21.7, P = .001 for granulomas, χ 2 = 19.0, P = .002 for lymphoid nodules, and χ 2 = 49.2, P = .001 for inflammation. We then analyzed how the 4 pathology scores correlated with the histologic diagnosis. As shown in Figure 3B and as confirmed by χ 2 analysis, lymphoid nodules do not discriminate among the various diagnoses (χ 2 = 19.0, P = .75). The quantification of fibrosis tends to be a useful discriminator, although the differences did not reach statistical significance (χ 2 = 13.6, P = .09).
On the other hand, either the detection of granulomas or the extent of inflammation had a nonrandom distribution among the diagnoses as determined by χ 2 analysis (granulomas χ 2 = 49.5, inflammation χ 2 = 58.2, P < .001 for both variables), although the inflammation pathology scores showed considerable overlap. An important question to address is whether the results could be attributed to medication use. Data on prednisone use were known for 25 individuals in this study. For the 6 participants receiving prednisone, the dosages were moderately high Figure 4 highlights those receiving prednisone therapy. Both of the participants with sarcoidosis who did not cluster with the other sarcoidosis biopsy specimens were taking prednisone at the time of the biopsy. The individual with GPA receiving prednisone appears to be shifted to the right as well. The use of corticosteroids is known to have major effects on gene expression
23
; therefore, it is plausible to speculate that their use influenced some results herein.
Finally, potential uses of gene expression profiling are to predict prognosis or to identify therapy that has a high likeli- hood of success. Although the size of the database and the duration of follow-up data in this cohort study are not adequate to address these issues thoroughly, one clinical vignette might be instructive. An individual who was included in the study had a history of well-documented Graves disease more than a decade before the onset of orbital disease. Her orbital imaging showed bilateral but asymmetric inflammation that involved the inferior and superior rectus muscles as well as orbital fat, the lacrimal glands, and the cavernous sinus. The radiologist thought that the findings were atypical for thyroid orbitopathy due to the lacrimal and sinus involvement. The pathologist read the biopsy results as nonspecific inflammation. Her gene expression profile also supported this conclusion, with a pattern of expression that fell into cluster 1 (as shown in Figure 1 ) rather than with the TED biopsy specimens. The patient responded to rituximab therapy, an approach that was not effective for TED in a randomized controlled trial.
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Discussion
Our observations based on gene expression indicate clearly that nonspecific inflammation within the lacrimal gland is a heterogeneous collection of diseases. The data suggest that a minority of patients with nonspecific lacrimal gland inflammation might have a localized form of sarcoidosis even if granulomas are not present in the biopsy specimen examined. Other examples of NSOI resemble either GPA or TED in terms of the pattern of gene expression. More detailed clinical information and more extensive follow-up data would help determine if these individuals followed different clinical courses that correlated with the gene expression profile. Our study found some degree of fibrosis, inflammation, and even lymphoid nodules among healthy controls, which corresponds well with what has been reported in minor salivary gland and lacrimal gland biopsy specimens.
26 Some degree of fibrosis and lymphoid nodularity is frequently detected in tissue samples from individuals who have no known abnormality regarding function of these glands. The clustering on the basis of gene expression subdivided the biopsy samples into groups that correlated with the pathology scores more consistently than categorizing the tissue on the basis of a diagnosis (ie, GPA, or sarcoidosis, or TED). Either grouping (ie, by gene expression or by diagnosis) reveals that the 4 pathology scores (fibrosis, granulomas, lymphoid nodules, and inflammation) do not reliably subdivide the tissue samples based on the overlap shown in Figure 3 .
Limitations
Our study has some limitations. The international centers might have varied in their clinical approach (eg, the acceptable duration of symptoms) before biopsy. They might also have differed as to pharmacologic treatment before biopsy. In addition, the length of time that the biopsy specimen was in fixative could have influenced the integrity of the RNA. Furthermore, our data on the clinical course of study participants were somewhat limited. Finally, some of our data suggest that oral corticosteroid use influences gene expression, 23 but we did not have adequate data to assess other medication use. We also emphasize that our observations on corticosteroid use are based on a small number of individuals receiving a high dosage of prednisone. In a prior study 13 on orbital adipose tissue that focused on a different set of transcripts, our group could not show that corticosteroid use affected gene expression. Additional study of this issue is warranted.
Conclusions
Despite these limitations, this investigation is arguably the largest study to date on gene expression in lacrimal inflammation and the first, to our knowledge, to definitively show the heterogeneity of NSOI in the lacrimal gland. Prior studies on gene expression in the lacrimal gland 27 or in the lacrimal accessory gland 28 were limited to normal tissue samples. Our analysis supports the conclusion that some patients with nonspecific lacrimal gland inflammation might have a limited form of GPA, sarcoidosis, or even TED.
Furthermore, our findings demonstrate how patterns of gene expression can provide data that complement the information gleaned by light microscopy. 
